P1.16-56 Prognostic Ability of New T1 Descriptors in the TNM Classification of Surgically Treated Non-Small Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1025
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prognostic Impact of Newly Proposed M Descriptors in TNM Classification of Non–Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

P3.12-16 Prognostic Impact of M Descriptors of the 8th Edition of TNM Classification for Extensive Disease-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.16-03 Prognostic Significance of PD-L1 in Stage II/III Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

The New TNM Classification of Lung Cancer in Practice

Breathe
PulmonaryRespiratory Medicine
2011English

P1.16-54 the Significance of Multiple Lung Cancer Occurrence in Surgically-Treated Clincal Stage I Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Effects of Biological Markers on Overall Survival in Surgically Treated Patients With Non Small Cell Lung Cancer

Vojnosanitetski Pregled
MedicinePharmacology
2020English

Prognostic Significance of CD276 in Non-Small Cell Lung Cancer

Open Medicine (Poland)
Medicine
2019English

P1.16-37 Clinicopathological Characteristics and Prognostic Factors of Operable Non-Small Cell Lung Cancer Patients With the Diabetes Mellitus

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Roles of Fhit and P53 in Taiwanese Surgically Treated Non-Small-Cell Lung Cancers

British Journal of Cancer
Cancer ResearchOncology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy